AlphaCore Capital »

Takeda Pharmaceutical shares owned by AlphaCore Capital

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by AlphaCore Capital from 13F filings

Historical chart of AlphaCore Capital investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by AlphaCore Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by AlphaCore Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $346k 22k 15.59
2025-09-30 $576k 39k 14.64
2025-06-30 $192k 12k 15.46

More positions owned by AlphaCore Capital

Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Meta Platforms Cl A (META)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Schwab Strategic Tr Fundamental Us L (FNDX)
MPLX Com Unit Rep Ltd (MPLX)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Vanguard Index Fds Large Cap Etf (VV)
Schwab Strategic Tr Fundamental Intl (FNDF)
Apple (AAPL)
Ishares Tr Core Msci Total (IXUS)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation Call Option (MSFT)
Etf Ser Solutions Distillate Us (DSTL)
Wisdomtree Tr Intl Qulty Div (IQDG)

View all positions for AlphaCore Capital

Top funds holding Takeda Pharmaceutical

Capital Research Global Investors
Arrowstreet Capital, Limited Partnership
Goldman Sachs Group
FMR
UBS Group
Brandes Investment Partners
Toronto-Dominion Bank
BlackRock
Millennium Management
Renaissance Technologies
First Trust Advisors
Van Eck Associates Corp.
Northern Trust
Citadel Advisors
Managed Asset Portfolios

View all funds holding Takeda Pharmaceutical